(NASDAQ: IFRX) Inflarx Nv's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.69%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.82%.
Inflarx Nv's earnings in 2025 is -$50,819,538.On average, 4 Wall Street analysts forecast IFRX's earnings for 2025 to be -$51,487,819, with the lowest IFRX earnings forecast at -$67,069,659, and the highest IFRX earnings forecast at -$40,648,278. On average, 4 Wall Street analysts forecast IFRX's earnings for 2026 to be -$48,777,934, with the lowest IFRX earnings forecast at -$63,004,831, and the highest IFRX earnings forecast at -$37,260,922.
In 2027, IFRX is forecast to generate -$59,278,739 in earnings, with the lowest earnings forecast at -$69,102,073 and the highest earnings forecast at -$49,455,405.